| 51 | 6-{4-[3-(4-methylpiperazin-1-yl)propoxy]-3-(trifluoromethyl)phenyl}pyridine-2-carbonitrile |
COVPDB422 |
 |
1 |
| 52 | 6-cyano-UMP |
COVPDB307 |
 |
3 |
| 53 | 7-cyano-7-deazaguanine |
COVPDB850 |
 |
3 |
| 54 | 7-cyclohexyl-6-{[4-(4-methylpiperazin-1-yl)phenyl]methyl}-7H-pyrrolo[2,3-d]pyrimidine-2-carbonitrile |
COVPDB645 |
 |
1 |
| 55 | AZ12878478 |
COVPDB1150 |
 |
1 |
| 56 | AZ13010160 |
COVPDB549 |
 |
1 |
| 57 | B4Z inhibitor |
COVPDB25 |
 |
1 |
| 58 | C4Z inhibitor |
COVPDB26 |
 |
1 |
| 59 | C6Z inhibitor |
COVPDB28 |
 |
1 |
| 60 | Cov_HetLib030 |
COVPDB1428 |
 |
1 |
| 61 | Cov_HetLib053 |
COVPDB1427 |
 |
1 |
| 62 | CP12 |
COVPDB896 |
 |
1 |
| 63 | CRA-26871 |
COVPDB614 |
 |
1 |
| 64 | CRA-27566 |
COVPDB652 |
 |
1 |
| 65 | CRA-27934 |
COVPDB653 |
 |
1 |
| 66 | CRA-29728 |
COVPDB603 |
 |
1 |
| 67 | DL-propargylglycine |
COVPDB125 |
 |
1 |
| 68 | (E)-1-(1-methyl-6-{4-[3-(4-methylpiperazin-1-yl)propoxy]-3-(trifluoromethyl)phenyl}-1H-imidazo[4,5-c]pyridin-4-yl)methanimine |
COVPDB753 |
 |
1 |
| 69 | GNE0775 |
COVPDB670 |
 |
1 |
| 70 | IC-3 |
COVPDB150 |
 |
1 |
| 71 | L-873724 |
COVPDB1143 |
 |
1 |
| 72 | M4Z inhibitor |
COVPDB27 |
 |
1 |
| 73 | methyl 4-[({[(2R,5S)-5-[(2S)-2-cyanopyrrolidine-1-carbonyl]pyrrolidin-2-yl]methyl}carbamoyl)amino]benzoate |
COVPDB476 |
 |
1 |
| 74 | MORPHOLINE-4-CARBOXYLIC ACID [1S-(2-BENZYLOXY-1R-CYANO-ETHYLCARBAMOYL)-3-METHYL-BUTYL]AMIDE |
COVPDB571 |
 |
1 |
| 75 | N-(1-CYANOCYCLOPROPYL)-3-({[(2S)-5-OXOPYRROLIDIN-2-YL]METHYL}SULFONYL)-N~2~-[(1S)-2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)ETH YL]-L-ALANINAMIDE |
COVPDB651 |
 |
1 |
| 76 | N-[(1S)-2-{[(1R)-2-(benzyloxy)-1-cyano-1-methylethyl]amino}-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide |
COVPDB1482 |
 |
1 |
| 77 | N-[(1S)-2-{[(3S)-1-benzyl-3-cyanopyrrolidin-3-yl]amino}-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide |
COVPDB1481 |
 |
1 |
| 78 | N-[(1S)-2-[(4-cyano-1-methylpiperidin-4-yl)amino]-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide |
COVPDB1480 |
 |
1 |
| 79 | N2-[(BENZYLOXY)CARBONYL]-N1-[(3S)-1-CYANOPYRROLIDIN-3-YL]-L-LEUCINAMIDE |
COVPDB1138 |
 |
1 |
| 80 | N-(4,4-dimethyl-2-prop-1-ynyl-3,1-benzoxazin-6-yl)-2-[3-methoxy-5-[(7-methoxy-4-quinolyl)oxy]-2-pyridyl]acetamide |
COVPDB1161 |
 |
1 |
| 81 | N-benzyl-2-cyanopyrimidine-5-carboxamide |
COVPDB159 |
 |
2 |
| 82 | N-benzyl-3-(2-cyano-6-propylpyrimidin-4-yl)-N-[2-(dimethylamino)ethyl]-5-(trifluoromethyl)benzamide |
COVPDB1169 |
 |
1 |
| 83 | N-(cyanomethyl)-2-({3-[2-(3,5-dichlorophenyl)-2-methylpropanoyl]-4-methoxyphenyl}formamido)acetamide |
COVPDB203 |
 |
1 |
| 84 | N-Cyanomethyl-Nalpha-(diphenylacetyl)-3-methylphenylalaninamide |
COVPDB484 |
 |
1 |
| 85 | NVP-ABE854 |
COVPDB945 |
 |
1 |
| 86 | NVP-ABI491 |
COVPDB946 |
 |
1 |
| 87 | NVP-ABJ688 |
COVPDB947 |
 |
1 |
| 88 | Odanacatib |
COVPDB350 |
 |
1 |
| 89 | p-nitrophenyl iodoisocyanide |
COVPDB1256 |
 |
1 |
| 90 | Saxagliptin |
COVPDB568 |
 |
1 |
| 91 | saxagliptin M2 |
COVPDB617 |
 |
1 |
| 92 | (S)-N-(6-(5-Phenyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-2,3-dihydro-1H-inden-1-yl)cyanamide |
COVPDB831 |
 |
1 |
| 93 | tert-Butyl ((1-((3S,5S)-5-((S)-2-Cyanopyrrolidine-1-carbonyl)-1-(4-phenylbutanoyl)pyrrolidin-3-yl)-1H-1,2,3-triazol-4-yl)methyl)carbamate |
COVPDB990 |
 |
1 |
| 94 | vildagliptin |
COVPDB1061 |
 |
2 |